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Abstract
Traumatic brain injury is a well-recognized environmental risk
factor for developing Alzheimer’s disease. Repetitive con-
cussive brain injury (RCBI) exacerbates brain lipid peroxida-
tion, accelerates amyloid (Ab) formation and deposition, as
well as cognitive impairments in Tg2576 mice. This study
evaluated the effects of vitamin E on these four parameters in
Tg2576 mice following RCBI. Eleven-month-old mice were
randomized to receive either regular chow or chow-supple-
mented with vitamin E for 4 weeks, and subjected to RCBI
(two injuries, 24 h apart) using a modified controlled cortical
impact model of closed head injury. The same dietary regi-
mens were maintained up to 8 weeks post-injury, when the
animals were killed for biochemical and immunohistochemical
analyses after behavioral evaluation. Vitamin E-treated ani-
mals showed a significant increase in brain vitamin E levels
and a significant decrease in brain lipid peroxidation levels.
After RBCI, compared with the group on regular chow, ani-
mals receiving vitamin E did not show the increase in Ab
peptides, and had a significant attenuation of learning deficits.
This study suggests that the exacerbation of brain oxidative
stress following RCBI plays a mechanistic role in accelerating
Ab accumulation and behavioral impairments in the Tg2576
mice.
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Alzheimer’s disease (AD) is the most common form of
dementia in the elderly (Ritchie and Lovestone 2002). It is
characterized by two types of protein aggregates, neuroﬁbr-
illary tangles and amyloid (Ab) plaques, mainly distributed
in brain areas that are involved in learning and memory. The
most common form of AD is sporadic AD (SAD), account-
ing for more than 90% of all disease cases. While apolipo-
protein E e4 allele is the best-documented genetic risk factor
for SAD (Corder et al. 1993; Saunders et al. 1993; Stritt-
matter et al. 1993), traumatic brain injury (TBI) represents
the most robust environmental AD risk factor (Schoﬁeld
et al. 1997; Nemetz et al. 1999; Plassman et al. 2000;
Jellinger et al. 2001). TBI has been shown to induce an
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increase in cerebrospinal ﬂuid (CSF) Ab levels (Raby et al.
1998), as well as Ab deposition in the human brain (Nicoll
et al. 1995), and Ab plaques have been found within days
after a single incident of TBI in humans (Roberts et al. 1991;
Graham et al. 1995). However, recent conﬂicting results
have also been reported (Franz et al. 2003; Kay et al. 2003).
Formation of reactive oxygen species and subsequent
oxidative damage has been extensively shown in TBI
(Lewen et al. 2000; Marklund et al. 2001). Oxidative
damage to the CNS predominantly manifests as lipid
peroxidation (LPO) because of the high content of polyun-
saturated fatty acids in the brain that are particularly
susceptible to oxidation. Isoprostanes (iPs) are speciﬁc and
sensitive markers of LPO in vivo (Pratico` et al. 2001a) and
have been shown to increase following experimental TBI in
rats (Pratico` et al. 2002). Further, we have shown that brain
LPO correlates with amyloid plaque formation and depos-
ition in the Tg2576 mice, a mouse model of AD-like brain
amyloidosis which overexpresses mutant human Ab precur-
sor protein (APPswe; Hsiao et al. 1996; Pratico` et al.
2001b).
Previously, using this mouse model we have provided
experimental evidence in support of a linkage between TBI
and AD, showing that repetitive concussive brain injury
(RCBI) accelerates brain Ab accumulation and behavioral
impairments, which were coincident with an exacerbation of
brain LPO (Uryu et al. 2002). In the present study, we took a
step further and investigated whether in this model exacer-
bation of the oxidative stress response is mechanistically
linked to the acceleration of the AD-like phenotype in the
Tg2576 mice undergoing RCBI. For this purpose, we
randomized Tg2576 mice to either receive regular chow or
chow supplemented with a potent exogenous antioxidant,
vitamin E, and we subjected them to RCBI. Here, we report
that vitamin E, by suppressing the exacerbation of brain LPO
following RBCI, prevents Ab peptide accelerated formation
and behavioral deﬁcits in these mice. These ﬁndings support
the hypothesis that increased oxidative stress response plays
a functional role in the accelerated amyloidogenic response
after RCBI, and that antioxidant therapies could decrease the
risk of AD associated with previous episodes of brain
trauma.
Materials and methods
Animals and surgical procedure
All the procedures were performed in accordance with the National
Institutes of Health Guide for the Care and Use of Laboratory
Animals, and the Institutional Animal Care and Use Committee
(IACUC) of the University of Pennsylvania approved them.
At 11 months of age, Tg2576 female mice were randomized to
receive either a regular chow or chow supplemented with 2 IU/g diet
vitamin E. The choice of using only female mice was based on
previous work showing that in this animal model females exhibit a
more consistent and greater amount of Ab formation and deposition
than males (Callahan et al. 2001). Preliminary experiments demon-
strated that the selected dose of vitamin E signiﬁcantly reduces in
vivo LPO (Pratico` et al. 1998a). The animals were kept in the same
dietary regimen for all the duration of the study. At 12 months of
age, Tg2576 mice were subjected to concussive brain injury (CBI)
repetitively (RCBI) as described previously (Laurer et al. 2001).
Brieﬂy, mice were anesthetized with inhalation anesthesia via a nose
cone using 2% isoﬂurane; ointment was applied to their eyes to
protect corneas during surgery. The mice were kept on a heating pad
to maintain body temperature throughout the surgical procedures.
All animals were mounted in a stereotactic frame; a skin incision
was performed to expose the skull; and the mice remained in the
stereotactic apparatus while subjected to RCBI using a pressure-
driven instrument that is mechanically identical to a previously
described controlled cortical impact device (Dixon et al. 1991;
Smith et al. 1995) with minor modiﬁcations previously described
(Laurer et al. 2001). In order to obtain a concussive injury, which
better recapitulates the features of a diffuse injury, we replaced the
standard tip with a less rigid and with larger diameter (9 mm)
silicone impounder. Using a larger, more compliant tip provided a
method to distribute impact energy over a larger surface of the brain
and also allowed deformation to encompass more of the brain. The
impounder was rigidly mounted at an angle of 20 from vertical, the
depth and duration of the impact were kept constant, and head
movements were minimal while delivering the load. The impounder
was driven at 4.8–5.0 m/s to a depth of 2.5 mm lower than the zero
point, causing a non-penetrating concussive blow to the head. The
procedure was completed with the closure of the incision using 4-0
silk sutures. The animals were removed from the stereotactic frame
and placed in a heated cage, and after recovery from anesthesia (as
evidenced by ambulation), they were returned to their home cages.
Twenty-four hours after the ﬁrst CBI, the animals were anesthetized
as described above and subjected to a second CBI in the same
location over the left parietotemporal region. Sham-treated animals
also were anesthetized and placed in the stereotactic frame; the
incision was sutured closed without brain injury on two consecutive
days thereby following exactly the surgical procedures of repetitive
CBI.
Neurobehavioral analysis
The testing paradigm for evaluation of cognitive function using the
Morris water maze (MWM) has been described in detail previously
(Smith et al. 1991, 1995). Brieﬂy, the MWM is a circular pool 1 m
in diameter, painted white inside (Morris et al. 1982). The water
(18–22C) is made opaque by adding non-toxic, water-soluble white
coloring. To test for RCBI-induced learning impairments, animals
received no training in the MWM before injury and were tested for
their ability in locating a stationary, submerged platform (0.5 cm
below the surface) using external clues within a maximum of 60 s
for each trial, during four trials/day over an 8-day period starting at
8 weeks after injury. The essential feature of the MWM is that mice
can escape from the water onto the platform after being placed
randomly at one of four sites in the pool. Latencies of four trials/day
were recorded and averaged to obtain a measurement for the
performance of each animal on a given day. Analysis was always
performed in a coded fashion. The composite neuroscore, which
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includes a battery of motor tests, was obtained for all mice before
performing MWM evaluations as previously described (Uryu et al.
2002). Each animal was scored by an investigator blinded to the
injury status or treatment of the animals.
Histological and immunohistochemical analysis
Eight weeks post-injury mice were anesthetized (sodium pentobar-
bital i.p., 65 mg/kg) and then transcardially perfused with phos-
phate-buffered saline (PBS; 0.1 M, pH 7.4) followed by 10% neutral
buffered formalin. The brains were removed, post-ﬁxed overnight,
sliced into 2-mm-thick coronal slabs, and embedded in parafﬁn in a
frontal to occipital series of blocks, and the blocks were cut in a near
serial array of 6-lm thick coronal sections. Parafﬁn sections were
subjected to immunohistochemistry (IHC) as previously described
(Murai et al. 1998; Nakagawa et al. 1999, 2000). Ab deposits were
visualized by NAB228, Ab monoclonal antibody (mAb; Lee et al.
2003). Our preliminary study revealed that NAB228 and 4G8
showed identical staining patterns. Brieﬂy, sections were deparaff-
inized in xylene and hydrated in a series of ethanol, subsequently
subjected to treatment with formic acid (88%; 20 min), methanol
(150 mL)-hydrogen peroxide (33% 30 mL; 30min), and fetal bovine
serum (4%) in Tris-buffer (0.1 M, pH 7.4) before applying the
primary antibody NAB228 (1 : 10 000 dilution) at 4C. The
sections were incubated with the primary antibody overnight (17–
20 h). Subsequently, the biotinylated anti-mouse IgG and the
avidin–biotin complex method were used according to the instruc-
tions of the vendor (Vector Laboratories, Burlingame, CA, USA).
Negative controls included the application of the exact same IHC
protocol, except pre-immune serum was applied instead of primary
antibody.
Image analysis
For the quantitative analysis, seven to eight sections from each
animal between )1.2 and )1.8 relative to bregma (Franklin and
Paxinos 1997) were always analyzed in a coded fashion and
altogether in a single experiment. They were stained with NAB228
antibody and not counterstained. The quantitative image analysis
was carried out as described previously with minor modiﬁcations
(Uryu et al. 2002). Light microscopic images from the somatosen-
sory cortex (SSC), peri-hippocampal cortex (PHC), and hippocam-
pus (HP) from both ipsilateral (left) and contralateral (right)
hemispheres to the RCBI site were captured from eight series of
sections using a Nikon Microphot-FXA microscope with a 4·
objective lens. Using a personal computer, each image was opened
with image analysis software (Image Pro-plus; Media Cybernetics,
Inc., Silver Spring, MD, USA). Manual editing was then performed
to eliminate non-speciﬁc signals (e.g. blood vessels and staining
artifacts). The areas occupied by Ab-immunoreactive products in the
regions of interest were measured, and the total area occupied by the
outlined structures was measured to calculate:
1. the total area with selected immunoreactive products;
2. the percentage of the area occupied by immunoreactive
products over the outlined anatomical area in the image.
The analysis was always performed in a coded fashion.
Sandwich Ab ELISA
For quantiﬁcation of Ab brain levels, brains were removed, and both
right and left cerebral cortex, hippocampus, and cerebellum were
separated, collected in individual test tubes, weighed, and immedi-
ately frozen until analysis. Sequential extraction of samples was
performed with high salt buffer and formic acid to measure soluble
and insoluble brain Ab (x-40) and Ab(x-42/43) levels. Cerebral
cortices, hippocampus, and cerebellum homogenates were serially
extracted in high salt reassembly buffer (0.1 M Tris, 1 mM EGTA,
0.5 mM MgSO4, 0.75 MNaCl, and 0.02 M NaF, pH 7.0) containing a
protease inhibitor mixture (pepstatin A, leupeptin, N-tosyl-L-
phenylalanine chloromethyl ketone, Na-p-tosyl-L-lysine chloro-
methyl ketone, and soybean trypsin inhibitor, each at 1 lg/mL in
5 mM EDTA). Homogenates were centrifuged at 100 000 g for 1 h
at 4C. Supernatants were removed, and pellets re-suspended in
70% formic acid, and re-sonicated and centrifuged at 100 000 g for
1 h at 4C. Supernatants were removed and diluted 1 : 20 with 1 M
Tris base. Extracted samples were normalized to their original wet
weight and analyzed separately by enzyme-linked immunosorbent
assay (ELISA). To do this, they were diluted in buffer EC [0.02 M
sodium phosphate, 0.2 M EDTA, 0.4 M NaCl, 0.2% bovine serum
albumin (BSA), 0.05% 3-[(3-cholamidopropyl) dimethylammonio]-
1-propane-sulfonic acid, 0.4% Block-ace (Dainippon; Suita, Osaka,
Japan), and 0.05% sodium azide, pH 7.0] and analyzed using Ban50
as the capturing mAb and BA-27 and BC-05 mAbs to detect Ab1–
40 and Ab1–42, respectively, as described previously (Wang et al.
1999; Nakagawa et al. 2000; Uryu et al. 2002). The analysis was
always performed in a coded fashion.
Quantification of vitamin E and isoprostane
Aliquots of brain tissue homogenates were used for iPs and vitamin
E analysis. Brieﬂy, vitamin E levels were assayed by high-
performance liquid chromatography (HPLC; Pratico` et al. 1998a),
while 8,12-iso-iPF2a-VI by a standardized gas chromatography/
mass spectrometry assay, as previously described (Pratico` et al.
2001b). All the assays were always performed without knowledge
of the treatment group of the mice.
Statistical analysis
Levels of vitamin E, 8,12-iso-iPF2a -VI, Ab1–40 and Ab1–42
concentrations and Ab deposits were expressed as mean ± SD. Data
from left and right hemispheres were compared by paired t-test.
Averages of the two hemispheres were compared by unpaired t-test.
Data obtained in the MWM are parametric and are given as mean ±
SD. These data were analyzed using a one-way ANOVA for repeated
measures (learning effect, treatment effect). Signiﬁcance was always
set at p < 0.05.
Results
Brain levels of vitamin E and 8,12-iso-iPF2a-VI
isoprostane
Starting at 11 months of age, Tg2576 mice were randomized
to receive normal chow (n ¼ 13) or chow supplemented with
vitamin E (2 IU/g diet; n ¼ 9). After 4 weeks, mice were
subjected to RCBI and kept on the same diets for an
additional 8 weeks, then killed. At this time, the treated
group had vitamin E plasma levels signiﬁcantly higher
(p < 0.01) than the control group (50.6 ± 4.2 lM and
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20.8 ± 3.9 lM, respectively). Levels of brain vitamin E and
8,12-iso-iPF2a-VI obtained from both cortex and hippocam-
pus homogenates were also measured. Differences between
right and left side were not found and values obtained were
averaged for both hippocampus and cortex. In both regions,
while no difference was observed between sham-operated
and the RBCI-group on regular chow (18 ± 2 vs.
21 ± 2.5 pg/mg tissue), vitamin E brain levels increased in
the RCBI-treated mice on vitamin E-supplemented diet
(38 ± 3.5 pg/mg tissue, p < 0.01). Compared with the sham-
treated mice, mice undergoing RCBI showed in the same
regions a signiﬁcant increase in 8,12-iso-iPF2a-VI levels,
which was prevented in the vitamin E group (p < 0.01;
Fig. 1).
Neurobehavioral analyses
When we tested the motor function of all mice, we did not
observe any sign of functional impairment (not shown).
Conﬁrming our previous study (Uryu et al. 2002), we
observed that compared with sham-operated, Tg2576 mice
subjected to RCBI manifest a signiﬁcant cognitive impair-
ment in the MWM test. However, RCBI-treated Tg2576
animals fed vitamin E-supplemented diet (n ¼ 8) demon-
strated a better ability in learning to locate the platform than
mice on regular chow (n ¼ 10; RM ANOVA p < 0.01; Fig. 2).
Ab ELISA
Next, we tested whether or not vitamin E modulates
accumulation of Ab peptides in the brain following RCBI
by a sensitive sandwich ELISA analysis. We measured levels
of Ab1–40 and Ab1–42 in the high salt and formic acid
soluble fractions from cortex and hippocampus homogenates.
Conﬁrming previous results (Uryu et al. 2002), there was no
difference between the ipsilateral side and contralateral side
to injury in the brain from normal diet group (p ¼ 0.81), as
well as that from vitamin E diet group (p ¼ 0.70). Similarly,
we found that, compared with the sham group, RCBI-treated
mice showed an increase in both Ab1–40 (4.8 ± 1.8 vs.
8 ± 2 pmol/g tissue, p < 0.05) and Ab1–42 (36 ± 8 vs.
48 ± 6 pmol/g tissue, p < 0.05). However, brains from the
RCBI-treated mice receiving vitamin E showed a sig-
niﬁcant reduction in Ab1–42 in both high salt and formic
acid soluble fractions in the cortex and hippocampus (Figs 3
and 4) compared to the ones on regular chow. Furthermore,
while we did not observe an effect in the cortex levels of
formic acid-soluble Ab1–40, hippocampal levels were lower
in vitamin E group compared to the control group (p < 0.01;
Fig. 4)
Amyloid deposition
Eight weeks after RCBI, all analyzed brains showed various
amounts of Ab deposition widely distributed in the cerebral
cortex and hippocampus as shown by the pan-Ab antibody,
NAB228. Conﬁrming previous results (Uryu et al. 2002), we
observed that 8 weeks after RBCI there was no signiﬁcant
difference in amyloid deposition between sham- and RBCI-
treated on regular chow (not shown). Further, we observed
that the distribution pattern of Ab deposition was infrequent
and uneven whether or not the RBCI-treated mice were on
the normal diet (n ¼ 5) or vitamin E-supplemented diet
(n ¼ 4). To determine whether or not vitamin E had an effect
on amyloid deposition following RCBI, the area occupied by
Ab-immunoreactive deposits in the SSC, PHC, and HP both
ipsilateral and contralateral hemisphere to the impact site
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Fig. 1 Levels of 8,12-iso-iPF2a-VI in cortical (ctx) and hippocampal
(hp) homogenates from sham-operated (open bars) or RCBI-treated
Tg2576 on regular chow (hatched bar), or vitamin E (closed bar),
results are expressed as mean ± SD (*p < 0.01).
Fig. 3 Levels of high salt soluble Ab 1–40 and Ab 1–42 in cortex and
hippocampus (hippo) homogenates from Tg2576 receiving regular
chow (n ¼ 7; h) or vitamin E (n ¼ 6; j). Results are expressed as
mean ± SD (*p < 0.01).
Fig. 2 Data from MWM testing from Tg2576 mice receiving regular
chow (d) or vitamin E (j). Trials were made in consecutive 8-day
sessions at 8 weeks after injury (one-way RM ANOVA, learning over
time: p < 0.01, treatment effect: p < 0.01).
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were analyzed. First, there was no signiﬁcant difference in
the amyloid burden between injured and contralateral side
(SSC, p ¼ 0.41; HP, p ¼ 0.26; PHC, p ¼ 0.32) of the brains
of mice undergoing RCBI. Second, while there was a trend
toward reduction in Ab burden in the vitamin E diet group
when compared to the normal diet group, it did not reach
statistical signiﬁcance (SSC, p ¼ 0.17; HP, p ¼ 0.14; PHC,
p ¼ 0.18).
Discussion
The present study shows that in the Tg2576 mice undergoing
RBCI vitamin E treatment by reducing the exacerbation of
brain LPO, prevents Ab peptides accumulation and behavi-
oral deﬁcits. These ﬁndings suggest that, in this animal
model, RCBI-dependent increase in brain oxidative stress
plays a functional role in accelerating of the AD-like
phenotype.
Despite the fact that epidemiological studies have implica-
ted recurrent brain trauma as a potent environmental risk
factor for developing AD, the mechanism(s) responsible for
this have yet to be completely elucidated (Nandoe et al.
2002). Thus, for years the relationship between experimental
TBI and brain amyloidosis has been characterized by
conﬂicting results. Reports have shown that following
controlled cortical impact (CCI), the APP-YAC mice do
not develop plaques when evaluated acutely after injury
(Murai et al. 1998), and in PD-APP mice, CCI produces a
marked ipsilateral hippocampal atrophy, almost complete
CA3-CA2 cell loss and diminished Ab deposition during
aging (Smith et al. 1998; Nakagawa et al. 1999, 2000). On
the contrary, in PD-APP mice subjected to CCI brain injury,
amyloid deposition is accelerated only in the presence of
APO-E4 while cell loss is not inﬂuenced (Hartman et al.
2002).
Recently, we have developed a new mild TBI mouse
model that does not require craniotomy, produces minimal
structural brain damage, and induces a progressive cell
dysfunction instead of cell loss (Laurer et al. 2001; Uryu
et al. 2002). This model more closely mimics the type of
human injuries that predispose individuals who survive
episodes of TBI to develop AD later in life. This experi-
mental paradigm has emerged as a more appropriate model
than CCI to study the relationship between TBI and the
development of amyloidosis. Previously, we have shown
that, in Tg2576 mice, RBCI induces an exacerbation of brain
LPO which is coincidental with an acceleration in Ab
formation and deposition, and cognitive impairments (Uryu
et al. 2002). In the present study, we conﬁrmed this
observation and provided strong evidence supporting the
hypothesis that exacerbation of the brain oxidative stress
response secondary to the experimental head traumatic injury
is the responsible factor for the acceleration of the AD-like
phenotype in Tg2576 mice undergoing RBCI.
For a long time it has been known that reactive oxygen
species and oxidative stress are constant features of the post-
TBI syndrome, however, the functional role of this phenom-
enona has been less clear (Hall et al. 1993; Shohami et al.
1997; Marklund et al. 2001). In the last 10 years the presence
of signature markers of oxidative stress has been widely
described for AD brains (Smith et al. 2000). Recent evidence
from animal models and human studies suggest the novel
concept that oxidative stress is an early and functional event
in AD pathogenesis (Nunomura et al. 2001; Pratico` 2002).
Interestingly, in our previous study, both single and repetitive
mild TBI exacerbated brain LPO in Tg2576, but single mild
TBI to a lesser extent than repetitive, and the latter was
associated with a more signiﬁcant increase in the amyloid-
ogenic response (Uryu et al. 2002).
Isoprostanes (iPs) are chemically stable isomers of
prostaglandins; they are formed by a free radical peroxidation
of polyunsaturated fatty acids and are sensitive and speciﬁc
markers of LPO in vivo (Pratico` et al. 2001a). They are
selectively increased in affected regions of AD brains as well
as in CSF of patients with AD (Pratico` et al. 1998b, 2000;
Montine et al. 1999), and correlate with the amount of
amyloid deposited in the Tg2576 (Pratico` et al. 2001b).
Vitamin E is the most important lipid-soluble chain-
breaking natural antioxidant in mammalian cells (Pratico
2001). In the past 20 years, many studies have conclusively
demonstrated that its principal function is to defend tissue
against oxidative damage, although other biological proper-
ties have also been described (Parks and Traber 2000).
Previous studies have shown that vitamin E is able to cross
the blood–brain barrier and, with time, accumulate at
therapeutic levels in the CNS, where it signiﬁcantly reduces
lipid peroxidation (Veinbergs et al. 2000). Moreover, we
have shown that high-dose vitamin E is effective in
modulating amyloid levels and deposition in Tg2576 only
when administered at an early stage of its phenotype (Sung
et al. 2004). Based on previous published work, in the
current study, vitamin E was given at the same concentration
and, most importantly, at an age that coincides with the initial
phase of the amyloid deposition (11 months; Kawarabayashi
et al. 2001; Pratico` et al. 2001b). In this experimental
Fig. 4 Levels of formic acid soluble Ab 1–40 and Ab 1–42 in cortex
and hippocampus (hippo) homogenates from Tg2576 receiving regu-
lar chow (n ¼ 7; h) or vitamin E (n ¼ 6; j). Results are expressed as
mean ± SD (*p < 0.01).
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setting, vitamin E signiﬁcantly prevented the accelerated Ab
accumulation by reducing the exacerbation of brain LPO
secondary to the brain trauma, and improved behavioral
impairments in the Tg2576 that follow RCBI. This ﬁnding
supports a functional role for oxidative stress in regulating
the amyloidogenic response to brain trauma in vivo, and it is
consistent with some in vitro data showing that oxidative
stress can positively modulate APP metabolism and increase
in Ab formation (Misonou et al. 2000). Thus, previous
studies have shown that oxidants can indeed increased
BACE activity and amyloid formation in neuronal cell lines
(Tamagno et al. 2002).
Further, it is known that the levels of brain Ab are the
result of a balance between the amount produced in the CNS
with the amount cleared from the brain into the circulation
(DeMattos et al. 2002). Because in the present study we did
not measure circulating levels of Ab, we cannot exclude that
vitamin E effect was also mediated by this mechanism.
In the present study, despite a trend towards reduction, we
did not ﬁnd a signiﬁcant effect of vitamin E treatment on
plaque deposition. This is because the mice were analyzed at
a relatively short time after RCBI (8 weeks), and we have
already shown that only after 16 weeks following RCBI
there is a signiﬁcant effect on plaque load (Uryu et al. 2002).
Another possible explanation is the small number of mice
analyzed together with the variability in plaque deposition
that characterizes this model (Hsiao et al. 1996).
In summary, our data support the hypothesis that TBI
accelerates the development of the AD-like phenotype in the
Tg2576 by exacerbating brain oxidative stress responses. We
conclude that antioxidant therapies should be undertaken at
the earliest possible time in individuals who survive an
episode of TBI in order to reduce the higher risk of
developing AD, which has been reported in these individ-
uals.
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